SonarMed

Biotechnology, Health Care
Founded in 2005-01-01
Indianapolis, Indiana, United States
For Profit

About SonarMed

SonarMed was founded in 2005 to commercialize technology licensed from Purdue University to improve the placement and monitoring of endotracheal (breathing) tubes (also known as ETTs or artificial airways) which are used in patients who cannot breathe on their own. The technology was initially developed at Purdue University by SonarMed founders Jeffrey Mans-field, Eduardo Juan and George Wodicka, using the principles of acoustic reflectometry in tubes to provide the medical community with a more comprehensive approach to assist in the maintenance of breathing tubes.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 2 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 12082051 USD
  • Last Funding: 3000000 USD (Series C)
  • Funding Status: Late Stage Venture

Technology Stack

SonarMed actively uses 2 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care

Headquarters: Indianapolis, Indiana, United States